Close

Novavax (NVAX) Announces Positive Top-Line Data from RSV F Vaccine Phase 2 in Infants

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. JNJ
4. AMD
5. GS
6. BAC
7. MS
8. UNH
9. BK
10. ITCI


Go back to Novavax (NVAX) Announces Positive Top-Line Data from RSV F Vaccine Phase 2 in Infants
Novavax, Inc. (NASDAQ: NVAX) Delayed: 3.95 -0.17 (4.13%)
Previous Close $4.12    52 Week High $9.23 
Open $4.07    52 Week Low $1.16 
Day High $4.11    P/E N/A 
Day Low $3.95    EPS $-0.30 
Volume 2,801,556